NFASC p.Ser820=
c.2460C>T · rs61741829 · VCV3037774
Benign
No assertion criteria
Classification
Benign
ClinVar
Review
No assertion criteria ☆☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Common
common (popmax 7.49%, mid) — too common for a highly-penetrant pathogenic allele
Conditions
1
NFASC-related disorder
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| REVEL | 0.236 | benign-leaning |
|---|---|---|
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
| Constraint at this position | ||
| Conservation | phyloP -20 | GERP -5 |
| Overall | ||
| CADD | 0.281 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
gnomAD v4.1 · exomes + genomes
Grpmax group
7.49%
Middle Eastern · 440/5,874 alleles
Filtering AF
6.91%
ClinGen BA1/BS1 input
FAF95, joint · FAF99 6.69%
Overall
2.77%
43,473/1,570,408 alleles · common
exomes 40,432/1,418,152 · genomes 3,041/152,256 · joint denominator
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Middle Easterngrpmax | 7.49% | 13 |
| South Asian | 5.45% | 18 |
| Ashkenazi Jewishnot grpmax-eligible | 3.74% | 27 |
| Remaining individualsnot grpmax-eligible | 2.89% | 35 |
| European (non-Finnish) | 2.88% | 35 |
| Admixed American | 1.86% | 54 |
| Finnishnot grpmax-eligible | 1.3% | 77 |
| Amishnot grpmax-eligible | 0.658% | 152 |
| African / African-American | 0.573% | 175 |
| East Asian | 0.1% | 995 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- NFASC
- Protein
- p.Ser820=
- Coding
- c.2460C>T
- MANE Select
- NM_001005388
- dbSNP
- rs61741829
- Type
- single nucleotide variant
- Location
- chr1:204982010 (GRCh38)
- Gene constraint
- LOEUF 0.362 · pLI 1.00 (gnomAD)
- Structure
- AlphaFold pLDDT 77.23 · 2 PDB
- Residue 820
- the fibronectin type-iii 2 domain
Disease context
NFASC-related disorder
Similar variants
- NFASC p.Ser820Pro Pathogenic same residue
- NFASC c.1831+11A>G Benign same condition
- NFASC c.2470+2131G>A Likely benign same condition
- NFASC c.3020-9G>A Likely benign same condition
- NFASC c.3290-9C>T Likely benign same condition
- NFASC c.536-4A>G Likely benign same condition
- NFASC c.*1C>T Likely benign same condition
- NFASC p.Ala1103= Benign same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nfasc-p-ser820 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown